| ||
| Top of the Charts at ASCO 2011 MedPage Today Possibly practice-changing clinical trial results in breast cancer, involving the aromatase inhibitor exemestane (Aromasin), caught Phend's attention, as did what may be a new standard of care for gastrointestinal stromal tumors. ... See all stories on this topic » | ||
| Bio-prospectors race to save unique plants for drug research Vancouver Sun Heinrich cites the famous case of taxol -a compound now widely used to treat breast cancer -which was discovered in the 1960s but was not available as a drug on the market until more than 25 years later. Then there is the problem of supply -in the case ... See all stories on this topic » | ||
| Local thermographer responds to FDA warning about misleading women KSBY San Luis Obispo News You may recall, KSBY News ran a story last month about Central Coast Thermography, which offers a no-contact, non-invasive way to screen for breast cancer. A week after our story aired, the FDA released an alert stating thermography is not an ... See all stories on this topic » | ||
| Bicarbonate and dichloroacetate: Evaluating pH altering therapies in a mouse ... 7thSpace Interactive (press release) Recently, it has been shown that buffering of extracellular acidity through systemic administration of oral bicarbonate can inhibit the spread of metastases in a mouse model for metastatic breast cancer. While these findings are compelling, ... See all stories on this topic » | ||
| Seattle Genetics, Agensys announce co-development of second antibody-drug ... pharmabiz.com Preclinically, ASG-22ME has demonstrated potent antitumour activity, including regressions in models of established breast, bladder and lung cancer. The antibody is attached to a potent, synthetic cytotoxic agent, monomethyl auristatin E (MMAE), ... See all stories on this topic » | ||
| ||
| Lowering protein in cancer cells may aid radiation therapy Daily News & Analysis According to the study, the gene for cyclin D1 is the second most-over expressed gene found in human cancers, including breast cancer, colon cancer, lymphoma, melanoma, and prostate cancer. Cyclin D1's normal function is to temporarily remove a ... See all stories on this topic » | ||
| MIT professor wins prestigious chemistry prize Boston Globe (blog) "Ladies' girdles to make an artificial heart, mattress stuffing as a breast implant. I thought we could use chemistry and chemical engineering principles to design thing from scratch." Langer runs a large, 100-person laboratory at MIT's Koch Institute ... See all stories on this topic » | ||
| Health Sector Receives Minor Boost Afrique en Ligue Uhuru said Sh150 million will be used to purchase modern equipments for screening cervical and breast cancer. "I have also all located from this amount Sh534 million toward finalization of rehabilitation of health facilities initiated under the ... See all stories on this topic » | ||
| Options Brief: Celsion Corporation Benzinga Its lead product ThermoDox is being evaluated in a Phase III clinical trial for primary liver cancer and a Phase II study for recurrent chest wall breast cancer. When it comes to investing, you cannot settle for anything less than the fastest and most ... See all stories on this topic » | ||
| Privacy paradox: Bad guys steal your data; good guys can't touch it msnbc.com For example, if researchers are studying the impact of exercise on breast cancer patients, they need to identify a control group from the general population to pair up with the experimental group. It's no small task -- a scientist might need to find ... See all stories on this topic » | ||
|
| ||
| Tesetaxel Results from Multiple Dose-Ranging Clinical ... - Drugs.com "We continue to expand the profile of tesetaxel use in combination with drugs that comprise the standard-of-care in gastric cancer and breast cancer, our priority indications. Early clinical data suggest confirmatio n of preclinical ... Drugs.com - Clinical Trials |
| ||
| APP Pharma launches generic breast cancer drug - Health - Cancer ... Days after a study indicated that hormone-blocking pills called aromatase inhibitors can reduce the risk of breast cancer, generic drugmaker APP ... www.msnbc.msn.com/.../app-pharma-launches-generic-breast-... |
This once a day Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment